PEComa

You have access
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature
KRISTEN D. STARBUCK, RICHARD D. DRAKE, G. THOMAS BUDD and PETER G. ROSE

Anticancer Research November 2016, 36 (11) 6161-6164;
You have access
Effective Therapeutic Intervention and Comprehensive Genetic Analysis of mTOR Signaling in PEComa: A Case Report
FLEUR WEEBER, MARCO J. KOUDIJS, MARLOUS HOOGSTRAAT, NICOLLE J.M. BESSELINK, STEF VAN LIESHOUT, ISAAC J. NIJMAN, EDWIN CUPPEN, G. JOHAN OFFERHAUS and EMILE E. VOEST

Anticancer Research June 2015, 35 (6) 3399-3403;
You have access
A Retrospective Study of Patients with Malignant PEComa Receiving Treatment with Sirolimus or Temsirolimus: The Royal Marsden Hospital Experience
CHARLOTTE BENSON, JOANNA VITFELL-RASMUSSEN, MARCO MARUZZO, CYRIL FISHER, NINA TUNARIU, SCOTT MITCHELL, OMAR AL-MUDERIS, KHIN THWAY, JAMES LARKIN and IAN JUDSON

Anticancer Research July 2014, 34 (7) 3663-3668;

Main menu